Regeneron Reports Third Quarter 2026 Financial and Operating Results
Revenue$5.1 billion+36% YoY
EPS$18.45
Outlookissuedguidance
Company · REGN
Regeneron Pharmaceuticals, Inc.
Earnings coverage
0Articles
1Earnings releases
0Topics
Jan 28Next earnings
REGN
Regeneron Pharmaceuticals, Inc. · NASDAQ NMS - GLOBAL MARKET
$927.89
▲ +109.12 (+13.33%)
Open$869.43
Prev close$818.77
Day low$839.08
Day high$935.35
52-week high$859.34
52-week low$591.52
Market cap$95.5B
Avg volume0.6M
P/E (TTM)22.07
EPS (TTM)$40.45
Div. yield0.40%
Beta0.12
Revenue growth+9.29%
Net margin27.9%
ROE13.8%
Shares out.103.0M
Delayed up to 15 min · Source: Finnhub · Not investment advice
Market data
Widgets by TradingView. They load only when you click, so the page stays fast.